JOHNSON DAVID LEE
SEC insider (Form 3/4/5 filer). CIK 0001733883. Chief Operating Officer at Vera Therapeutics, Inc. (VERA) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Feb 23, 2026. Located in BRISBANE, CA.
Companies JOHNSON DAVID LEE has filed insider reports for
- Vera Therapeutics, Inc. (VERA): Officer, Chief Operating Officer
- Caribou Biosciences, Inc. (CRBU): Director
JOHNSON DAVID LEE
CIK: 0001733883
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Feb 23, 2026VERA
Vera Therapeutics, Inc.
SaleDirect2.6K shares at avg. $41.98$108K - Feb 20, 2026CRBU
Caribou Biosciences, Inc.
AwardDirectOption to purchase Common Stock
45K shares- - Feb 4, 2026VERA
Vera Therapeutics, Inc.
AwardDirect20K shares- - Feb 20, 2025CRBU
Caribou Biosciences, Inc.
AwardDirectOption to purchase Common Stock
40.5K shares- - Feb 18, 2025VERA
Vera Therapeutics, Inc.
AwardDirect26.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 23, 2026 |  VERA Vera Therapeutics, Inc. | Sale | 2,579 | $41.98 | $108,276 | Direct |
| Feb 20, 2026 |  CRBU Caribou Biosciences, Inc. | Award Option to purchase Common Stock | 45,000 | - | - | Direct |
| Feb 4, 2026 | VERA Vera Therapeutics, Inc. | Award | 20,000 | - | $0 | Direct |
| Feb 20, 2025 | CRBU Caribou Biosciences, Inc. | Award Option to purchase Common Stock | 40,500 | - | - | Direct |
| Feb 18, 2025 | VERA Vera Therapeutics, Inc. | Award | 26,900 | - | - | Direct |
1-5 of 5 transactions